Log in to save to my catalogue
Log in to save to my catalogue

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: c...

| Ask | Become a Library member

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8359627

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

About this item

Full title

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Author / Creator

Hoertel, Nicolas , Sánchez-Rico, Marina , Cougoule, Céline , Gulbins, Erich , Kornhuber, Johannes , Carpinteiro, Alexander , Becker, Katrin Anne , Reiersen, Angela M. , Lenze, Eric J. , Seftel, David , Lemogne, Cédric and Limosin, Frédéric

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2021-12, Vol.26 (12), p.7098-7099

Language

English

Formats

Articles

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

More information

Alternative Titles

Full title

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8359627

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8359627

Other Identifiers

ISSN

1359-4184

E-ISSN

1476-5578

DOI

10.1038/s41380-021-01254-3

How to access this item

Log in as a Library member

Full text available

About resource

About resource

View in old catalogue

Connecting people and collections